LUNGevity has materials available to help you learn about lung cancer, raise awareness in your community, and find out about our vital services and support for lung cancer survivors and their loved ones.
Our Patient Education Series offers 12 comprehensive booklets, written and illustrated clearly to help patients understand their diagnosis and treatment options. Available titles cover each type of lung cancer, NSCLC staging, clinical trials, biomarker testing, and various treatment types.
Tri-fold brochures are available for lung cancer stages and treatment options, as well as our support services.
For Healthcare Professionals
Booklets and brochures are available at no charge in quantities of 25 or more. See the order form for details.
For Patients, Caregivers, and Advocates
If you are a lung cancer patient or caregiver, you'll find the facts you need in easy-to-understand language to help you be your own best advocate in your healthcare at this critical time. Our booklets and brochures can be downloaded and printed at home for your convenience.
Advocates interested in distributing print materials in their community or to their local clinic can make requests for materials through their LUNGevity contacts.
Click on a title to download the document as a PDF:
Comprehensive Booklets
About detection:
About types and stages of lung cancer:
About testing and treatments:
Brochures and Flyers
About detection:
About lung cancer staging:
About treatments:
About biomarker testing:
Biomarker testing quick facts flyer
Biomarker testing conversation starter
Biomarker testing discussion guide for HCPs
5 things to know about your biomarker test report
About what to expect after diagnosis:
Navigating Lung Cancer: The Patient Journey
About LUNGevity and our services:
About LUNGevity: Improving Outcomes
Our support services: Get Connected
Stay Informed
The Patient Education Series continues to expand and booklets are periodically revised to keep pace with current research and practice. Sign up for our monthly e-newsletter to get the latest news.